Qingxiang Zhang

Key Laboratory Of Organ Regeneration And Transplantation Of The Ministry Of Education
Changchun, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Cleavage of TOM1 by the SARS-CoV-2 main protease NSP5 prevents autophagic degradation of viral envelope.

Cleavage of TOM1 by the SARS-CoV-2 main protease NSP5 prevents autophagic degradation of viral envelope.

Journal: Journal of virology

Published: June 12, 2026

Host OTUB2 and viral plpro stabilize NSP8 to promote SARS-CoV-2 replication.

Host OTUB2 and viral plpro stabilize NSP8 to promote SARS-CoV-2 replication.

Journal: Virologica Sinica

Published: March 24, 2026

RNF31 restricts EV-A71 replication through innate immune activation and VP4 degradation, and is antagonized by viral 3C proteases.

RNF31 restricts EV-A71 replication through innate immune activation and VP4 degradation, and is antagonized by viral 3C proteases.

Journal: PLoS pathogens

Published: March 02, 2026

Diagnostic and therapeutic potential of resolvin D1 in Guillain-Barré syndrome.

Diagnostic and therapeutic potential of resolvin D1 in Guillain-Barré syndrome.

Journal: Journal of advanced research

Published: July 02, 2025

Amelioration of experimental autoimmune encephalomyelitis by exogenous soluble PD-L1 is associated with restraining dendritic cell maturation and CCR7-mediated migration.

Amelioration of experimental autoimmune encephalomyelitis by exogenous soluble PD-L1 is associated with restraining dendritic cell maturation and CCR7-mediated migration.

Journal: International immunopharmacology

Published: June 29, 2024

The chemically stable analogue of resolvin D1 ameliorates experimental autoimmune encephalomyelitis by mediating the resolution of inflammation.

The chemically stable analogue of resolvin D1 ameliorates experimental autoimmune encephalomyelitis by mediating the resolution of inflammation.

Journal: International immunopharmacology

Published: May 25, 2024

Specialized pro-resolving lipid mediators: a key player in resolving inflammation in autoimmune diseases.

Specialized pro-resolving lipid mediators: a key player in resolving inflammation in autoimmune diseases.

Journal: Science bulletin

Published: April 30, 2024

FGF/FGFR system in the central nervous system demyelinating disease: Recent progress and implications for multiple sclerosis.

FGF/FGFR system in the central nervous system demyelinating disease: Recent progress and implications for multiple sclerosis.

Journal: CNS neuroscience & therapeutics

Published: June 20, 2022

Elevated serum interleukin-39 levels in patients with neuromyelitis optica spectrum disorders correlated with disease severity.

Elevated serum interleukin-39 levels in patients with neuromyelitis optica spectrum disorders correlated with disease severity.

Journal: Multiple sclerosis and related disorders

Published: February 21, 2020

The GTF2I rs117026326 polymorphism is associated with neuromyelitis optica spectrum disorder but not with multiple sclerosis in a Northern Han Chinese population.

The GTF2I rs117026326 polymorphism is associated with neuromyelitis optica spectrum disorder but not with multiple sclerosis in a Northern Han Chinese population.

Journal: Journal of neuroimmunology

Published: April 22, 2019

Underestimated Cervical Extradural Hematoma Secondary to the Small Needle-Scalpel for the Treatment of Cervical Spondylosis: A Rare but Avoidable Complication.

Underestimated Cervical Extradural Hematoma Secondary to the Small Needle-Scalpel for the Treatment of Cervical Spondylosis: A Rare but Avoidable Complication.

Journal: Frontiers in neurology

Published: December 30, 2018

Showing 1-11 of 11

Last Updated: 09/26/2026